ストックスクリーナーアプリを入手
436.62
0.08%
-0.39
Vertex Pharmaceuticals Inc (VRTX) 最新ニュース
This Week’s CGT News: Vertex’s Gene Therapies Show Promise in Younger Children - The Medicine Maker
Wells Fargo Adjusts PT on Vertex Pharmaceuticals to $515 From $460, Maintains Overweight Rating - marketscreener.com
State Street Corp Has $5.24 Billion Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by SVB Wealth LLC - MarketBeat
Daiwa Securities Group Inc. Grows Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Axa S.A. Buys 10,477 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
ASH: Beam Can Rival Vertex In Sickle Cell But Bulsufan Deaths Cast A Shadow - Citeline News & Insights
Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat
Disney, Nu Holdings, Phillips 66 And A Health Care Stock On CNBC's 'Final Trades' - Benzinga
Vertex Will Seek Regulatory Approval for Casgevy in Younger Sickle Cell, Beta-Thalassemia Patients - Precision Medicine Online
Why Vertex Pharmaceuticals (VRTX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Vertex's Gene Therapy Works In Children With Blood Disorders - Benzinga
Thematics Asset Management Acquires 2,642 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions - BioSpace
David And Goliath: How A Parent-Led Buyers’ Club Challenged Cystic Fibrosis Giant Vertex - Citeline News & Insights
VRTX Stock Quote Price and Forecast - CNN
2 Stocks That Could Soar by 52% and 282%, According to Wall Street - The Motley Fool
Marshall Wace LLP Has $52.09 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
California Public Employees Retirement System Has $322.79 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Arrowstreet Capital Limited Partnership Purchases Shares of 61,470 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? - Nasdaq
Vertex Pharmaceuticals (NASDAQ:VRTX) Chairman Jeffrey Leiden Sells 63,781 Shares - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Charles Wagner Jr Sells 14,000 Shares - MarketBeat
Best Biotech Stocks To Watch NowDecember 6th - MarketBeat
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the - pharmiweb.com
Vertex presents new data on Casgevy at ASH - The Pharma Letter
Vertex Pharmaceuticals Incorporated Presents New Data on CASGEVY, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions - marketscreener.com
Vertex Presents New CASGEVY Data Highlighting Benefits In Children Ages 5-11 - Nasdaq
Vertex CRISPR therapy hits early goal in children with blood disorders - BioPharma Dive
Vertex's gene therapy shows promise in younger children with blood disorders - Reuters
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions - Via TT
Mirabella Financial Services LLP Reduces Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Epoch Investment Partners Inc. Sells 20,810 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
First Trust Advisors LP Purchases 143,084 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Insider Sell: WAGNER CHARLES F JR Sells 14,000 Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
Vertex Pharma executive chairman sells $28.6m in stock - Investing.com India
Vertex Pharmaceuticals Insider Sold Shares Worth $2,024,955, According to a Recent SEC Filing - marketscreener.com
VP Tatsis Sells 4,500 ($2M) Of Vertex Pharmaceuticals Inc [VRTX] - TradingView
Vertex Pharmaceuticals EVP Sells Shares Under Trading Plan - TradingView
VRTX Analyst Rating Update: Morgan Stanley Raises Price Target | VRTX Stock News - GuruFocus
Morgan Stanley Adjusts PT on Vertex Pharmaceuticals to $564 From $516, Maintains Overweight Rating - marketscreener.com
Can Vertex Pharmaceuticals Incorporated (VX1) stock sustain breakout momentumWeekly Trade Report & Technical Confirmation Trade Alerts - Newser
Why Vertex Pharmaceuticals Incorporated stock appeals to dividend seekers2025 Market Overview & Expert Curated Trade Ideas - Newser
Amundi Has $517.92 Million Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
1 Reason I'll Never Sell Vertex Pharmaceuticals Stock - Finviz
Citi Healthcare In Brief: Launch Trajectories Under Scrutiny - Citeline News & Insights
Is Vertex Pharmaceuticals Incorporated stock resilient to inflationWeekly Stock Report & Technical Confirmation Trade Alerts - Newser
Why Analysts See Vertex Pharmaceuticals Story Shifting With New Pipeline Momentum and Valuation Debates - Yahoo Finance
Harding Loevner Global Equity’s Views on Vertex Pharmaceuticals Incorporated (VRTX) - Insider Monkey
Vertex Pharmaceuticals (NASDAQ:VRTX) Raised to Overweight at Morgan Stanley - MarketBeat
Westerkirk Capital Inc. Acquires New Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (VRTX): Assessing Valuation After Recent Multi-Month Share Price Gains - Yahoo Finance
Invesco Ltd. Raises Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Why Vertex Pharmaceuticals Incorporated (VX1) stock stays resilientPortfolio Performance Summary & Smart Money Movement Tracker - Newser
CW Advisors LLC Buys 4,801 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Fisher Asset Management LLC Has $11.47 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Published on: 2025-12-03 23:31:46 - Newser
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MSN
Check Out What Whales Are Doing With VRTX - Benzinga
Vertex Pharmaceuticals (VRTX) Upgraded by Morgan Stanley with Op - GuruFocus
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today - Finviz
0.49%
0.32%
大文字化:
|
ボリューム (24 時間):